| Countries: | Ghana, Kenya, Senegal |
|---|
| Principle investigator(s): | Jayne Webster, Caroline Jones, Suzanne Welsh |
|---|
| Funder: | Pfizer CSR |
|---|
| Collaborator(s): | Health Partners Ghana (Ghana); KEMRI-Wellcome Trust (Kenya); IntraHealth (Senegal) |
|---|
| Started: | June 2007 |
|---|
| Duration: | 4 Years |
|---|
| Summary: | The aim of the programme is to help close the critical gaps in malaria treatment and education in Ghana, Kenya and Senegal. In Ghana the programme aims to help improve performance of the infomal sector (Licenced Chemical Sellers) in the recognition and treatment of malaria with ACTs (particularly children under five years of age) and in the timely referral of cases to the formal sector. In Kenya the aim is to work through the public health sector (primarily ante-natal clinics) to promote appropriate treatment seeking behaviour for malaria in the caretakers of children under five years of age. In Sengal the programme will also work through the public sector by training community health workers and nurses in the recognition, appropriate treatment and timely rteferral of malaria cases, particularly children under five years of age. Local independent monitoring and evaluation teams have been appointed in each country and the role of the TARGETS staff in this programme is to act as Global Advisors to these teams. The aim of the Global Advisory group is to oversee the monitoring and evaluation programmes in the three countries, to provide coordination as well as technical support and advisory services to the local (Ghanian, Kenyan and Senegalese) partners. |
|---|
| Demand for research: | As part of the Clinton Global Initative, prior to the development of the programme Pfizer undertook a rapid stakeholder analysis (interviews with over 100 malaria experts and stakeholders) in Ghana, Kenya and Senegal to identify gaps in the provision of treatment for malaria. Based on this analysis Pfizer designed and launched the complimentary interventions in the three countries. Key to the programme is a comprehensive evaluation of the interventions to provide an understanding of 'what matters' and 'what works'. |
|---|
| Target audience: | Ministries of Health and National Malaria Control Programmes. International donors and local, national and international NGOs. |
|---|
| Possible influence on policy & practice: | The results from the monitoring and evaluaiton of these interventions will provide information to policy makers not only on the effectiveness of each type of intervention, but also on the factors that constrain or enable the effective implementation of these types of intervention. |
|---|